NASDAQ: TLX
Telix Pharmaceuticals Ltd Stock Ownership - Who owns Telix Pharmaceuticals?

Insider buying vs selling

Have Telix Pharmaceuticals Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TLX insiders and whales buy or sell their stock.

TLX Shareholders

What type of owners hold Telix Pharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Portland Investment Counsel Inc0.08%266,200$2.09MInstitution
Lazard Asset Management LLC0.07%250,517$1.97MInstitution
Fmr LLC0.04%123,570$970.02kInstitution
Jpmorgan Chase Co0.02%74,368$583.79kInstitution
Marshall Wace LLP0.01%46,658$366.27kInstitution
Private Advisor Group LLC0.01%46,345$363.81kInstitution
Jane Street Group LLC0.01%40,042$314.33kInstitution
Quadrature Capital Ltd0.01%36,828$289.10kInstitution
Mariner LLC0.01%36,582$287.17kInstitution
Vident Advisory LLC0.01%27,249$213.90kInstitution

1 of 3

TLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TLX0.33%0.00%
ALMS74.53%25.47%Net BuyingNet Buying
RCUS68.34%31.66%Net SellingNet Selling
TVTX63.78%36.22%Net SellingNet Selling
BEAM86.40%13.60%Net SellingNet Selling

Telix Pharmaceuticals Stock Ownership FAQ

Who owns Telix Pharmaceuticals?

Telix Pharmaceuticals (NASDAQ: TLX) is owned by 0.33% institutional shareholders, 0.00% Telix Pharmaceuticals insiders, and 99.67% retail investors. Portland Investment Counsel Inc is the largest individual Telix Pharmaceuticals shareholder, owning 266,200.00 shares representing 0.08% of the company. Portland Investment Counsel Inc's Telix Pharmaceuticals shares are currently valued at $2.09M.

If you're new to stock investing, here's how to buy Telix Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.